For tumor stages, SLC30A1, SLC30A7 and SLC30A10 groups significantly varied, whereas SLC30A2, SLC30A3, SLC30A4, SLC30A5, SLC30A6, SLC30A8 and SLC30A9 did not significantly differ in cervical carcinoma (Figure 2). This evidence concerns the gene SLC30A2 and cervical carcinoma.